SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Rubius Therapeutics, Inc. – IPO: ‘S-1’ on 6/22/18 – ‘EX-21’

On:  Friday, 6/22/18, at 4:47pm ET   ·   Accession #:  1047469-18-4710   ·   File #:  333-225840

Previous ‘S-1’:  None   ·   Next:  ‘S-1/A’ on 7/2/18   ·   Latest:  ‘S-1/A’ on 7/9/18   ·   6 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 6/22/18  Rubius Therapeutics, Inc.         S-1                   18:11M                                    Merrill Corp/New/FA

Initial Public Offering (IPO):  Registration Statement (General Form)   —   Form S-1
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-1         Registration Statement (General Form)               HTML   1.86M 
 2: EX-3.1      Articles of Incorporation/Organization or By-Laws   HTML    145K 
 3: EX-3.2      Articles of Incorporation/Organization or By-Laws   HTML     35K 
 4: EX-3.3      Articles of Incorporation/Organization or By-Laws   HTML     98K 
 5: EX-3.4      Articles of Incorporation/Organization or By-Laws   HTML    114K 
 6: EX-4.2      Instrument Defining the Rights of Security Holders  HTML    306K 
 7: EX-4.3      Instrument Defining the Rights of Security Holders  HTML     53K 
 8: EX-4.4      Instrument Defining the Rights of Security Holders  HTML     53K 
 9: EX-10.1     Material Contract                                   HTML    264K 
11: EX-10.10    Material Contract                                   HTML     29K 
12: EX-10.11    Material Contract                                   HTML    750K 
13: EX-10.12    Material Contract                                   HTML    261K 
14: EX-10.13    Material Contract                                   HTML    243K 
15: EX-10.14    Material Contract                                   HTML     74K 
16: EX-10.15    Material Contract                                   HTML     73K 
10: EX-10.4     Material Contract                                   HTML     19K 
17: EX-21       Subsidiaries                                        HTML      8K 
18: EX-23.1     Consent of Experts or Counsel                       HTML      9K 


EX-21   —   Subsidiaries


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]




Exhibit 21

 

SUBSIDIARIES

 

Subsidiary

 

Jurisdiction of Incorporation

Rubius Therapeutics Securities Corporation

 

Massachusetts

 




6 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/27/23  Rubius Therapeutics, Inc.         10-K       12/31/22   77:7.2M
 6/08/22  Rubius Therapeutics, Inc.         S-3                    6:1M                                     Toppan Merrill/FA
 5/10/22  Rubius Therapeutics, Inc.         S-8         5/10/22    4:63K                                    Toppan Merrill/FA
 2/25/22  Rubius Therapeutics, Inc.         10-K       12/31/21   74:10M                                    Toppan Merrill Bridge/FA
 5/10/21  Rubius Therapeutics, Inc.         S-8         5/10/21    3:110K                                   Toppan Merrill Bridge/FA
 2/23/21  Rubius Therapeutics, Inc.         10-K       12/31/20   82:12M                                    Toppan Merrill Bridge/FA
Top
Filing Submission 0001047469-18-004710   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Mar. 29, 8:08:49.1am ET